Second-Generation Antipsychotic Use in Pediatric Emergency Medicine. Issue 3 (March 2021)

• Record Type: Journal Article
• Authors: Lambert, Clare; Panagiotopoulos, Constadina; Davidson, Jana; Goldman, Ran D.
• Is Part Of: Pediatric emergency care. Volume 37:Issue 3(2021)
• Page Start: 161
• Page End: 164
• Publication Date: 2021-03
• Subjects: second-generation antipsychotics -- metabolic syndrome -- SGA monitoring; Pediatric emergencies -- Periodicals; 618.92002505
• DOI: 10.1097/PEC.0000000000002387
• Languages: English
• ISSNs: 0749-5161

Abstract

Abstract: In recent years, the number of patients presenting to the emergency department with mental health complaints has been growing, alongside an increase in second-generation antipsychotic (SGAs) prescriptions for a variety of mental health conditions. Children treated with SGAs may have abnormalities, such as rapid weight gain and central adiposity, glucose intolerance, dyslipidemia, and hypertension; they may present to the pediatric emergency department with components of metabolic syndrome or type 2 diabetes, and a subsequent significant risk for cardiovascular complications later in life. Pediatric emergency department providers may serve as a safety net for patients to detect SGA-related metabolic complications, especially among vulnerable populations lacking access to primary care or psychiatric services.